Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents-in celebration of 80th birthday of Professor Peter Riederer
Following introduction of the monoamine oxidase type B inhibitor selegiline for the treatment of Parkinson's disease (PD), discovery of the action mechanism of Alzheimer's disease-modifying agent memantine, the role of iron in PD, and the loss of electron transport chain complex I in PD, a...
Elmentve itt :
Szerzők: |
Tanaka Masaru Spekker Eleonóra Szabó Ágnes Polyák Helga Vécsei László |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2022
|
Sorozat: | JOURNAL OF NEURAL TRANSMISSION
129 No. 5-6 |
Tárgyszavak: | |
doi: | 10.1007/s00702-022-02513-5 |
mtmt: | 32848934 |
Online Access: | http://publicatio.bibl.u-szeged.hu/25533 |
Hasonló tételek
-
Editorial of Special Issue ‘Dissecting Neurological and Neuropsychiatric Diseases Neurodegeneration and Neuroprotection’ /
Szerző: Tanaka Masaru, et al.
Megjelent: (2022) -
Neuroprotection by Kynurenine Metabolites
Szerző: Majláth Zsófia, et al.
Megjelent: (2022) -
Albert Szent-Gyorgyi celebrates his 90th birthday
Megjelent: (1984) -
Kynurenines in the Pathogenesis of Multiple Sclerosis Therapeutic Perspectives /
Szerző: Biernacki Tamás, et al.
Megjelent: (2020) -
Spectrum of neurodevelopmental disabilities a cohort study in Hungary /
Szerző: Gergev Gyurgyinka, et al.
Megjelent: (2015)